期刊文献+

2010年广州市甲型H1N1流感病毒分离株NA基因变异分析 被引量:6

Analysis on the NA gene variation of influenza A(H1N1) virus from Guangzhou in 2010
下载PDF
导出
摘要 目的比较2010年从广州市分离到的甲型H1N1流感病毒神经氨酸酶(NA)基因与2009年中国大陆甲型H1N1流感病毒NA基因的变异情况,为甲型H1N1流感的监测和防控提供参考资料。方法收集2010年广州市有发热和呼吸道症状患者的咽拭子标本,用甲型H1N1流感病毒特异性引物进行聚合酶链反应(PCR)检测,扩增分离到的甲型H1N1流感病毒NA基因片段,测序后与2009年的H1N1毒株进行比对和进化分析,并用生物信息学方法对耐药位点和糖基化位点进行分析。结果共收集1 194份咽拭子标本,检测到甲型流感病毒阳性327份,其中H1N1流感病毒6株,与2009年分离的甲型H1N1流感病毒相比,有16个位点发生了有义突变,3个位点和NA活性相关,其中222位氨基酸的变异位于NA活性位点上。结论成功扩增了2010年广州市6株甲型H1N1流感病毒株NA基因并测序,未发现H275Y耐药位点的变异。3毒株在NA活性位点222位、228位和425位等氨基酸位点处发生了变异,需继续加强监测。 Objective To compare the variations of neuraminidase (NA) gene of influenza A ( H1 N1 ) virus from Guangzhou in 2010 and NA gene of influenza A ( H1N1 ) virus from Chinese mainland in 2009, and to provide the reference for the surveillance and prevention of influenza A ( H1N1 ) virus. Methods Specimens were collected from patients with febrile respiratory tract symptoms from Guangzhou in 2010. The specimens were determined with influenza A (H1N1) virus specificity primers by polymerase chain reaction (PCR). The fragment of NA gene was amplified. After sequencing, the results were compared with influenza A (H1N1) virus in 2009. The drug resistance sites and glycosylation sites were analyzed by biometric software. Results A total of 1 194 specimens were collected, and 327 influenza A virus strains were detected, including 6 strains were identified with influenza A ( H1 N1 ) virus. Compared with influenza A (H1N1) virus in 2009, there were 16 amino acid sites with variation. There were 3 amino acid sites relating with NA activity. However, the amino acid site 222 located in the NA activity sites. Conclusions NA geue of the 6 strains of influenza A (H1N1) virus are amplified and sequenced successfully, and H275Y drug resistant site is not found. The amino acid site 222, 228 and 425 locating in NA activity sites are found with mutations in 3 strains. Therefore, the monitoring should be strengthened.
出处 《检验医学》 CAS 2014年第1期42-49,共8页 Laboratory Medicine
基金 国家重大传染病防治科技重大专项(2009ZX10004-213) 广东省重大传染病专项
关键词 甲型H1N1流感病毒 神经氨酸酶 耐药位点 Influenza A ( H1 N1 ) virus Neuraminidase Drug resistance site
  • 相关文献

参考文献18

  • 1Fouchier RA,Munster V,Wallensten A. Char-acterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls[J].{H}Journal of Virology,2005,(05):2814-2822.
  • 2Smith GJ,Vijaykrishna D,Bahl J. Origins and evolutionary genomics of the 2009 swine-origin H1N1influenza A epidemic[J].{H}NATURE,2009,(7250):1122-1125.
  • 3WHO. Pandemic(H1N1)2009[OL].http://www.who.int/csr/disease/swinflu/laboratory 19_03_2010/en/,2010.
  • 4Shortridge KF. Severe acute respiratory syndrome and influenza:virus incursions from southern China[J].{H}American Journal of Respiratory and Critical Care Medicine,2003,(12):1416-1420.
  • 5Thompson JD,Higgins DG,Gibson TJ. CLUSTAL W:improving the sensitivity of progressive multiple sequence alignment through sequence weighting,position-specific gap penalties and weight matrix choice[J].{H}Nucleic Acids Research,1994,(22):4673-4680.
  • 6Tamura K,Dudley J,Nei M. MEGA4:mole-cular evolutionary genetics analysis(MEGA) soft-ware version 4.0[J].{H}Molecular Biology and Evolution,2007,(08):1596-1599.
  • 7Bright RA,Shay DK,Shu B. Adamantane re-sistance among influenza A viruses isolated early dur-ing the 2005-2006 influenza season in the United States[J].{H}JAMA:the Journal of the American Medical Association,2006,(08):891-894.
  • 8蓝雨,李梓,董丽波,张烨,温乐英,张彦明,王敏,郭元吉,舒跃龙.中国H3N2亚型流感病毒烷胺类药物耐药性研究[J].中华实验和临床病毒学杂志,2006,20(2):21-23. 被引量:25
  • 9Centers for Disease Control and Prevention(CDC). Update:drug susceptibility of swine-origin influenza A (H1N1)viruses,April 2009[J].{H}Morbidity and Mortality Weekly Report,2009,(16):433-435.
  • 10Smith BJ,McKimm-Breshkin JL,McDonald M. Structural studies of the resistance of influenza virus neuramindase to inhibitors[J].{H}Journal of Medicinal Chemistry,2002,(11):2207-2212.

二级参考文献8

  • 1Reuman PD,Bernstein DI,Keefer MC,et al.Efficacy and safety of low dosage amantadine hydrochloride as prophylaxis for influenza A.Antiviral Res,1989,11:27-40.
  • 2Belshe RB,Burk B,Newman F,et al.Resistance of influenza A virus to amantadine and rimantadine:results of one decade of surveillance.J Infect Dis,1989,159:430-435.
  • 3Belshe RB,Smith MH,Hall CB,et al.Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection.J Virol,1988,62:1508-1512.
  • 4Saiki RK,Gelfand DH,Stoffel S,et al.Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.Science,1988,239:487-491.
  • 5Bright RA,Medina MJ,Xu X,et al.Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005:a canse for concern.Lancet,2005,366:1175-1181.
  • 6Hay A J,Zambon MC,Wolstenholme A J,et al.Molecular basis of resistance of influenza A viruses to amantadine.J Antimicrob Chemother,1986,18 (Suppl B):S19-29.
  • 7Suzuki H,Saito R,Masuda H,et al.Emergence of amantadine-resistant influenza A viruses:epidemiological study.J Infect Chemother,2003,9:195-200.
  • 8Ziegler T,Hemphill ML,Ziegler ML,et al.Low incidence of rimantadine resistance in field isolates of influenza A viruses.J Infect Dis,1999,180:935-939.

共引文献24

同被引文献74

引证文献6

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部